This study investigated the psychometric properties of the Korean version of the Patient Activation Measure 13 (PAM13) using Rasch analysis. The sample consisted of 270 Korean patients with osteoarthritis. The PAM13 was translated into Korean using a standardized forward–backward translation approach. In this study, the Cronbach’s α coefficient was .88, the average interitem correlation was .34, and the average item–rest correlation was .55. The difficulty ranking of the item in this study differed from that in the original version. We did not need to collapse response categories. A total of 57.5% of the variance was explained by the residuals, indicating unidimensionality. The results suggest that the PAM13-K is a reliable and valid measure of activation. Further research is needed to validate item responsiveness and intervention effects.
American College of Rheumatology. (2012). Osteoarthritis. Retrieved December 2013, fromhttp://www.rheumatology.org
2.
BondT. G.FoxC. M. (2001). Applying the Rasch model. Fundamental measurement in the human sciences (1st ed.). Mahwah, NJ: Lawrence Erlbaum.
3.
Brenk-FranzK.HibbardJ. H.HermannW. J.FreundT.SzecsenyiJ.DjalaliS.…GenichenJ. (2013). Validation of the German version of the patient activation measure 13 (PAM13-D) in an international multicentre study of primary care patients. PLoS One, 8, e74786. Retrieved fromhttp://www.plosone.org
4.
ColemanK.AustinB. T.BrachC.WagnerE. H. (2009). Evidence on the chronic care model in the new millennium. Health Affairs, 28, 75–85.
5.
EmbretsonS. E.ReiseS. P. (2000). Item response theory for psychologists. Mahwah, NJ: Lawrence Erlbaum.
6.
HelmicC. G.FelsonD. T.LawrenceR. C.GabrielR. H.HirschR.KwohC. K.…StoneJ. H. (2008). Estimates of the prevalence of arthritis and other rheumatic conditions in the United States (Part I). Arthritis & Rheumatism, 58, 15–25.
7.
HibbardJ. H.GreeneJ.BeckerE. R.RoblinD.PainterM. W.PerezD. J.…TuslerM. (2008). Racial/ethnic disparities and consumer activation in health. Health Affairs, 27, 1442–1453.
8.
HibbardJ. H.GreeneJ.TuslerM. (2009). Improving the outcomes of disease management by tailoring care to the patient’s level of activation. American Journal of Managed Care, 15, 353–360.
9.
HibbardJ. H.MahoneyE. R.StockardJ.TuslerM. (2005). Development and testing of a short form of the Patient Activation Measure. Health Services Research, 40, 1918–1930.
10.
HibbardJ. H.StockardJ.MahoneyE. R.TuslerM. (2004). Development of the patient activation measure (PAM): Conceptualizing and measuring activation in patients and consumers. Health Sciences Research, 39, 1005–1026.
11.
HurN. W.ChoiC. B.UhmW. S.BaeS. C. (2008). The prevalence and trend of arthritis in Korea: Results from Korea National Health and Nutrition Examination Surveys. Journal of the Korean Rheumatism Association, 15, 11–26.
12.
LawrenceR. C.FelsonD. T.HelmicC. G.ArnoldL. M.ChoiH.DeyoR. A.…WolfeF. (2008). Estimates of the prevalence of arthritis and other rheumatic conditions in the United States (Part II). Arthritis & Rheumatism, 58, 26–35.
13.
LinacreJ. M. (1999). Investigating rating scale category utility. Journal of Outcome Measure, 3, 103–122.
14.
MaindalH. T.SokolowskiI.VedstedP. (2009). Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version. BMC Public Health, 9, 209. doi:10.1186/1471-2458-9-209
15.
MarshallR.BeachC.SahaS.MoriT.LovelessM. O.HibbardJ. H.…KorthuisP. T. (2013). Patient activation and improved outcomes in HIV-Infected patients. Journal of General Internal Medicine, 28, 668–674.
16.
MosenD. M.SchmittdielJ.HibbardJ.SobelD.RemmersC.BellowsJ. (2007). Is patient activation associated with outcomes of care for adults with chronic conditions?The Journal of Ambulatory Care Management, 30, 21–29.
17.
TennantA.ConaghanP. G. (2007). The Rasch measurement model in rheumatology: What is it and why use it? When should it be applied and what one should look for the in a Rasch paper. Arthritis Care & Research, 57, 1358–1362.
